National Comprehensive Cancer Network 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion
Discussion. In recognition of NCCN's 20th Anniversary, this special roundtable, moderated by Clifford Goodman, PhD, The Lewin Group, featured NCCN leadership-past and present-as well as other stakeholders who have had a significant... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 13, 2015 Category: Cancer & Oncology Source Type: news
NCCN Publishes New Guidelines for Smoking Cessation
Written for the treatment of smokers diagnosed with cancer, the NCCN Guidelines® for Smoking Cessation recommends treatment plans that include evidence-based pharmacotherapy and behavior therapy.
FORT WASHINGTON, PA - Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer dea... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 13, 2015 Category: Cancer & Oncology Source Type: news
Chemotherapy and Improved Surgical Techniques Noted as Important Advancements in Treating Ovarian Cancer over the Last Two Decades
NCCN has published the 20th annual edition of the NCCN Guidelines® for Ovarian Cancer, one of the original NCCN Guidelines published in November 1996.
FORT WASHINGTON, PA - Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States and is the country's fifth most common cause of cancer mortality in women. In 2015, it is estimated that more than 21,000 new diagnoses and more than 14,000 deaths from this neoplasm will occur in the United States; less th... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 12, 2015 Category: Cancer & Oncology Source Type: news
Clinical Trials, Advanced Genetic Profiling, Improved Patient Categorization Have Led to Improved Outcomes in Acute Myeloid Leukemia since 1996
NCCN has published the 20th annual edition of the NCCN Guidelines® for Acute Myeloid Leukemia, one of the original NCCN Guidelines published in 1996.
FORT WASHINGTON, PA - Acute Myeloid Leukemia is the most common form of acute leukemia among adults with more than 18,000 estimated diagnoses in 2014, and accounts for the largest number of annual deaths from leukemias in the United States.1
The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual edition of the NCCN ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 9, 2015 Category: Cancer & Oncology Source Type: news
Nccn 20
Approximately 1,500 oncology stakeholders are expected to attend NCCN's 20th Annual Conference: Advancing the Standard of Cancer Care™, March 12 - 14, 2015, in Hollywood, Florida.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) will host its 20th Annual Conference: Advancing the Standard of Cancer Care™, March 12 - 14, 2015, at The Diplomat in Hollywood, Florida. Approximately 1,500 physicians, nurses, pharmacists, and other oncology stakeholders and representatives o... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 8, 2015 Category: Cancer & Oncology Source Type: news
All Pain and No Gain: Increased Treatments, Cost and Side Effects Do Little in Increase Survival in Elderly Advanced Stage Colorectal Cancer Patients (University of Colorado Cancer Center)
A University of Colorado Cancer Center in the journal Medical Care shows that over a recent 10-year period, the rate of metastatic colorectal cancer patients older than age 75 receiving three or more treatments increased from 2 percent to 53 percent. During this period, 1-year treatment cost increased 32 percent to reach an estimated $2.2 billion annually. However, median survival for these patients increased by only one month.
University of Colorado Cancer Center is one of the 26 NCCN Member... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 25, 2015 Category: Cancer & Oncology Source Type: news
NCCN Publishes New Patient-Friendly Treatment Guidelines for Acute Lymphoblastic Leukemia
NCCN has published NCCN Guidelines for Patients®: Acute Lymphoblastic Leukemia (ALL), the newest addition to the library of NCCN Guidelines for Patients®.
FORT WASHINGTON, PA - According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.1
The National Comprehensive Cancer Network® (NCCN®) has published NCCN Guidelines for Patients®:... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 25, 2015 Category: Cancer & Oncology Source Type: news
CMS Oncology Care Model Names NCCN Guidelines as High-Quality Care and Evidence-Based Recommendations
Centers for Medicare & Medicaid Services encourages concordance to NCCN Guidelines for Medicare patients in order to achieve better care, smarter spending, and healthier people.
FORT WASHINGTON, PA - On Thursday, February 12, 2015, Centers for Medicare & Medicaid Services Innovation (CMS Innovation Center) announced an Oncology Care Model (OCM) with the goal to utilize appropriately aligned financial incentives to improve care coordination, appropriateness of care, and access to care ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 20, 2015 Category: Cancer & Oncology Source Type: news
Looking Back on Two Decades of Breast Cancer Treatment: Targeted Therapy and Improved Surgical Procedures are Key Enhancements
NCCN has published the 20th annual edition of the NCCN Guidelines® for Breast Cancer, one of the original NCCN Guidelines published in November 1996.
FORT WASHINGTON, PA - Breast cancer is the most frequently diagnosed cancer globally and the leading cause of cancer-related death in women. However, the incidence of breast cancer has somewhat stabilized over the past few decades, and breast cancer mortality appears to be declining[1], suggesting a benefit from the combination of early detectio... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 15, 2015 Category: Cancer & Oncology Source Type: news
NCCN Celebrates 20 Years of Improving Cancer Care
January 31, 2015 marks the 20th anniversary of the National Comprehensive Cancer Network; originally announced as an alliance of 13 leading cancer centers in 1995, NCCN has grown to a network of 25 academic cancer centers devoted to patient care, research, and education.
FORT WASHINGTON, PA - On January 31, 2015, the National Comprehensive Cancer Network® (NCCN®) celebrates its 20th anniversary. Originally announced as an alliance of 13 leading cancer centers in 1995, NCCN has grown to a netw... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 1, 2015 Category: Cancer & Oncology Source Type: news
Access to High-Quality Cancer Care Eliminates Racial Disparities in Survival, Study Finds
A recent Stanford Cancer Institute study shows that adherence to the NCCN Guidelines® for Colon Cancer in an integrated health care setting improves outcomes in all patients, including minorities.
FORT WASHINGTON, PA - African-American people diagnosed with colon cancer have consistently lower survival rates compared with white patients, despite a nationwide decline in colon cancer deaths overall.1 According to a new study published on January 26, 2015 by Journal of Clinical Oncology, this ga... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 29, 2015 Category: Cancer & Oncology Source Type: news
NCCN and Flatiron Health Announce Collaboration to Launch Novel Oncology Outcomes Database
A new collaboration between NCCN and Flatiron Health will provide the opportunity to analyze key quality and outcomes metrics and identify trends and patterns in the care of patients with cancer.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is collaborating with Flatiron Health to create a cloud-based data repository of NCCN Member Institution data - the NCCN Outcomes Database.
'The collaboration with Flatiron Health will provide oncology stakeholders the abilit... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 10, 2015 Category: Cancer & Oncology Source Type: news
Bad Luck of Random Mutations Plays Predominant Role in Cancer, Study Shows
Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells divide. By their measure, two-thirds of adult cancer incidence across tissues can be explained primarily by 'bad luck,' when these random mutations occur in genes that can drive cancer growth, while the remaining third are due to environmental factors and inherited genes.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 6, 2015 Category: Cancer & Oncology Source Type: news
1.5 Million Lives Spared by Cancer Death Rate Reduction in 20 Years, Study Says
This article features commentary from Dr. Michael Neuss, Chief Medical Officer at Vanderbilt-Ingram Cancer Center-one of the 25 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - December 31, 2014 Category: Cancer & Oncology Source Type: news
Immunotherapy, Genomic Profiling and Potential Game Changing Drugs Lead List of 2014 Dana-Farber Research Highlights
This press release describes highlights of the Dana-Farber Cancer Institute 2014 cancer research and clinical developments, including work in immunotherapy, genomic profiling, and investigating game-changing drug therapies.
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - December 30, 2014 Category: Cancer & Oncology Source Type: news
